Krasner Andrew Jay sold $515K of WTW (indirect holdings)
Krasner Andrew Jay (Chief Financial Officer) sold 1,525 indirectly-held shares of WILLIS TOWERS WATSON PLC (WTW) at $337.48 ($0.51M total) on 2026-11-13.
WILLIS TOWERS WATSON PLC
WTW is a global advisory, broking and solutions company serving organizations ranging from large multinational corporations to middle-market businesses, as well as governmental agencies and not-for-profit institutions. It advises on people, risk and capital, helping clients manage risk, benefits, talent and investment needs. WTW operates two integrated segments: Health, Wealth & Career and Risk & Broking. Its services include employee benefits and retirement consulting, investment advice and management, benefits administration, compensation and career programs, insurance brokerage, risk consulting, and technology and advice for the insurance industry. WTW acts as an intermediary between clients and insurance carriers, negotiating and placing insurance, and earns most of its revenue from brokerage commissions or consulting fees. It is not an insurance company and does not underwrite risks for its own account. The company is headquartered in London, England.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
Krasner Andrew Jay (Chief Financial Officer) sold 1,525 indirectly-held shares of WILLIS TOWERS WATSON PLC (WTW) at $337.48 ($0.51M total) on 2026-11-13.
Morgan Stanley kept Willis Towers Watson at Equal-Weight and raised its price target to $350 from $325. The new target implies 4.4% upside versus the Nov 13 close of $335.34. Other analysts’ targets in the past month ranged from $360 to $397.
Mizuho raised its price target for Willis Towers Watson to $384, up from $370, implying a 16.8% upside from the Nov 12 close. The firm maintained an Outperform rating. Recent analyst targets range from $360 to $397.
Over the past 7 days, AlphAI's AI scored 3 news stories mentioning WTW (WILLIS TOWERS WATSON PLC). Coverage has skewed bullish: 2 bullish, 1 neutral, and 0 bearish.
Recent WTW coverage spans financial news, insider activity and corporate actions.
In the last 30 days, WTW insiders filed 1 SEC Form 4 transaction — no purchases and 1 sale ($515K). The most active reporter was Krasner Andrew Jay, Chief Financial Officer, with 1 filing.
Routine insider selling under a Form 4, with no 10b5-1 plan stated, may slightly pressure sentiment but is unlikely to change fundamentals.
PT increase suggests modest bullish bias, but it is an analyst action rather than a new company fundamental.
Analyst target hike is likely to support near-term sentiment, but it is not a fundamental company event.
The partnership may modestly improve WTW's market perception and data licensing revenue.
Analyst upgrade suggests potential upside for the stock.
AlphAI scores every news story that mentions WTW with an AI model for sentiment and relevance, and aggregates insider trades from WILLIS TOWERS WATSON PLC's SEC EDGAR Form 4 filings. Figures refresh continuously.
Krasner Andrew Jay (Chief Financial Officer) sold 1,525 indirectly-held shares of WILLIS TOWERS WATSON PLC (WTW) at $337.48 ($0.51M total) on 2026-11-13.
Morgan Stanley kept Willis Towers Watson at Equal-Weight and raised its price target to $350 from $325. The new target implies 4.4% upside versus the Nov 13 close of $335.34. Other analysts’ targets in the past month ranged from $360 to $397.
Mizuho raised its price target for Willis Towers Watson to $384, up from $370, implying a 16.8% upside from the Nov 12 close. The firm maintained an Outperform rating. Recent analyst targets range from $360 to $397.
Pave and WTW (NASDAQ: WTW) have partnered to integrate WTW's compensation data into Pave's AI-powered platform. This allows mutual clients to use trusted market data for pay decisions, combining WTW's surveys with Pave's real-time intelligence. The agreement aims to streamline compensation workflows and enhance data-driven decision-making.
Keefe, Bruyette & Woods reaffirmed its Outperform rating for Willis Towers Watson and increased its price target to $397 from $360, suggesting a 17.7% upside from the last close. Recent analyst price targets for the company range from $332 to $395.
WILLIS TOWERS WATSON PLC (WTW) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. As previously disclosed by Willis Towers Watson Public Limited Company (the “Company”), Joseph Kurpis notified the Company
UBS kept its Buy rating on Willis Towers Watson but reduced its price target to $395 from $398, representing a 0.8% decrease. The new target suggests a 21.3% upside from the stock's recent close of $325.51. Recent analyst price targets for the company range from $310 to $371.
Wells Fargo kept its Overweight rating on Willis Towers Watson but reduced its price target to $360 from $364, a 1.1% decrease. This implies an 11.0% upside from the Oct 30 close of $324.42. Recent analyst price targets range from $310 to $371.
Willis Re completed its acquisition of BMS Re US, expanding its US reinsurance operations and adding capabilities in complex property and casualty risks. The deal includes BMS Intermediaries and BMS Capital Advisory, and was announced in August 2026. Financial terms were not disclosed. Willis Re aims to grow its platform and enhance client value with the acquisition.
Mizuho raised its price target on Willis Towers Watson (WTW) to $370 from $349, maintaining an Outperform rating. The stock trades at $324.42, suggesting 14% upside. Mizuho lowered earnings estimates but kept them above consensus. WTW reported Q3 2026 organic growth of 4%, meeting expectations, and exceeded Wall Street's earnings and revenue forecasts. Goldman Sachs and Raymond James also maintained positive ratings with higher price targets.